Cite
HARVARD Citation
van der Kooi, A. et al. (2022). 072 Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function. European journal of obstetrics, gynecology, and reproductive biology. pp. e30-. [Online].